ArticleWorld journal of oncology2019

Pretreatment Lung Immune Prognostic Index Is a Prognostic Marker of Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.

Seigo Minami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.